Traditional transit networks have been built on the basic assumption most riders would be departing their suburban homes for downtown in the morning and returning in the evening after work. “That ...

Barring traffic jams or disruptions on rapid-transit lines, commuting prior to the pandemic had a certain rhythm and predictability to it transit agencies could rely on day to day. But ridership now ...

The news: Seattle-based protein engineering company Cyrus Biotechnology has raised $18 million and acquired Orthogonal Biologics, a spinout from the University of Illinois at Urbana Champaign, which ...